Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Darwin Private Equity is a UK-based private equity firm that specializes in mid-market buyouts across various sectors, including healthcare, consumer, and business services. Founded in 2007 by former senior executives from Permira and CVC, the firm focuses on UK-based companies with enterprise values typically between £10 million and £100 million. In the healthcare and life sciences space, Darwin has made notable investments such as GenePlanet, a leading European genetic testing and laboratory services company, and previously owned Maxinutrition, a sports nutrition leader that was successfully sold to GSK. The firm is known for its hands-on approach, working closely with management teams to drive operational improvements and long-term growth in its portfolio companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Darwin Private Equity.